BOT botanix pharmaceuticals ltd

Objective Views on Lead product: BTX 1503 (Acne), page-6

  1. 2,895 Posts.
    lightbulb Created with Sketch. 611
    "However, the phase 2 results showed the primary endpoint in reduction in inflammatory lesions did not achieve statistical significance ..."

    This statement refers to the Australian results for Phase 2 BTX 1503 and is

    a serious departure from the truth.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.3¢
Change
-0.003(1.52%)
Mkt cap ! $318.6M
Open High Low Value Volume
16.5¢ 17.0¢ 16.0¢ $1.161M 7.032M

Buyers (Bids)

No. Vol. Price($)
99 5237772 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 674507 26
View Market Depth
Last trade - 14.22pm 29/07/2025 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.